Talaromyces marneffei (Segretain et al.) Samson et al.
商品貨號(hào)
B172125
Deposited As
Penicillium marneffei Segretain et al.
Strain Designations
SC-587 [CBS 549.77]
Application
Biomedical Research and Development Material
Emerging infectious disease research
Biosafety Level
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
frozen
Storage Conditions
Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section
Type Strain
no
Preceptrol®
no
Comments
infection
fluorescent antibody test
Medium
ATCC® Medium 325: Malt extract agar (Blakeslee's formula)
ATCC® Medium 336: Potato dextrose agar (PDA)
ATCC® Medium 2003: Czapek yeast extract agar
Growth Conditions
Temperature: 24°C to 26°C
Atmosphere: Typical aerobic
Name of Depositor
AF DiSalvo
Chain of Custody
ATCC <-- AF DiSalvo <-- K. Sherer
Isolation
Human spleen
References
DiSalvo AF, et al. Infection caused by Penicillium marneffei: description of first natural infection in man. Am. J. Clin. Pathol. 60: 259-263, 1973. PubMed: 4720403
Kaufman L, et al. Development of specific fluorescent-antibody test for tissue form of Penicillium marneffei. J. Clin. Microbiol. 33: 2136-2138, 1995. PubMed: 7559962
Mekha N, et al. The intergenic spacer region of the ribosomal RNA gene of Penicillium marneffei shows almost no DNA sequence diversity. Microbiol Immunol 54: 714-716, 2010. PubMed: 21155364
